BPA Call 36C24122A0124-36C24126N0614
Award Date 7/15/26
Potential Completion Date 7/14/27
Potential Value $35K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Roxbury, MA 02132, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1) awarded a firm fixed-price call order valued at $11,700 to Adaptive Biotechnologies Corporation for ClonoSEQ testing services. This award, dated July 15, 2024, represents a call against Adaptive's existing Blanket Purchase Agreement (BPA) with VISN 1, which carries a total ceiling value of $828,750 over a five-year period ending in July 2027. The work will be performed at the VA Medical Center in West Roxbury,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1) awarded a contract call to Adaptive Biotechnologies Corporation valued at $5,850.00 for ClonoSEQ testing services, with an ultimate completion date of July 14, 2025. This award is issued as a Blanket Purchase Agreement (BPA) call under Adaptive's existing single-award BPA with VISN 1, valued at $828,750 with a five-year ordering period through July 2027. The contract utilizes firm fixed-price pricing with no...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) to Adaptive Biotechnologies Corporation, doing business as Adaptive, for ClonoSEQ minimal residual disease testing services. The $9,750 contract call has a performance period through July 2023 and is part of a larger $828,750 single award BPA for ClonoSEQ services benefiting VA medical facilities in the New England region. The BPA...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Adaptive Biotechnologies Corporation, doing business as Adaptive, to provide ClonoSEQ minimal residual disease testing services for the Boston and West Haven VA health care systems. The contract has a ceiling value of $95,000.00 and a period of performance through July 2026. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products, and...
- The Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a firm fixed-price purchase order to Adaptive Biotechnologies Corporation for $243,750 on December 29, 2025, for ClonoSEQ testing, with completion by December 28, 2026. Work is performed in Cleveland, Ohio. The order carries no set-aside designation. The originating solicitation, posted November 4, 2025, was a sole-source special notice for molecular diagnostic testing services under simplified acquisition...
- This is a $385,920 firm fixed price definitive contract awarded by the Defense Health Agency to Adaptive Biotechnologies Corporation, doing business as Adaptive, to provide the ClonoSEQ Minimal Residual Disease In-Vitro Diagnostic Array for the Department of Pathology at the Walter Reed National Military Medical Center. The contract has a performance period ending on February 28, 2025 and does not have a set-aside designation. Adaptive Biotechnologies is a commercial provider of immune-driven...
- This federal contract award is for IMMUNOSEQ MMTCRB SERVICE (DEEP), catalog # ISS20001, with a quantity of 16, awarded to Adaptive Biotechnologies Corporation by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract has a firm fixed price of $16,560.00 and a completion date of July 31, 2025. This is not a set-aside contract. Adaptive Biotechnologies is a for-profit organization that specializes in...
- The Defense Health Agency awarded a definitive contract to Adaptive Biotechnologies Corporation for ClonoseQ FDA-cleared in vitro diagnostic testing services on March 14, 2025, with a ceiling value of $681,270 and no set-aside. Place of performance is JBSA Fort Sam Houston, TX. The contract is firm fixed price with an ultimate completion date of March 13, 2030. The originating solicitation calls for ClonoseQ FDA-cleared in vitro diagnostic testing services, which provide minimal residual disease...
- Veterans Integrated Service Network 19 issued a BPA call to Exact Sciences Corporation for Genomic Health genetic testing under the Medical Laboratory Testing and Analysis Services (FSS-621-II) GSA Schedule, with a ceiling value of $73,167.28 and an award date of October 1, 2024. Place of performance is Aurora, Colorado. The ultimate completion date is September 30, 2025. The call is firm fixed price. This is Option Year 4 of an existing BPA framework for specialized genomic and molecular...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA - VHA VISN 16) awarded Laboratory Corporation of America a $763,220.53 firm fixed price blanket purchase agreement (BPA) call contract to provide reference laboratory testing and analysis services, including COVID-19 antibody screening tests, to VISN 16. The contract was awarded under the Medical Laboratory Testing and Analysis Services Government-Wide Acquisition Contract (GSA Schedule...